ARCHIVES

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 28 No. 35 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

Senate Outlines Budget Priorities In Bill Report

July 19, 1991

NCI, Dialogue Plan A National Tissue Bank

July 11, 2003

Pharmacia Letter Announces Suspension Of Two Trials.

May 11, 2001

Symposium to Focus on New Approaches to Drug Resistance

May 11, 1990

In Brief: Chabner Says He ”Has No Intention Of Leaving NCI; “Yarbro Named Clinical Indicators Chairman

September 2, 1988

Also Anna Barker gets new, longer title at NCI; Mark Clanton named deputy director for care, delivery.

February 13, 2004